Loading…
Loading…
EQUITY / NASDAQ · XNCM
Cosmos Health Inc.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.38 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.38 USD · Volume 2,480,912
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 18,986,376 USD | 14,745,702 USD | +28.76% |
| Operating profit | -2,925,607 USD | -2,645,319 USD | — |
| Net income | -6,086,522 USD | -2,828,068 USD | — |
| Cash and cash equivalents | 1,800,949 USD | — | — |
| Total liabilities | 40,787,471 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,800,949 USD | — | — | 715,674 USD | 715,674 USD | 889,441 USD | — | — |
| Gross profitIncome statement | 1,511,662 USD | 2,892,833 USD | — | — | 7,895,575 USD | 2,602,618 USD | 5,816,231 USD | 1,163,814 USD |
| Net incomeIncome statement | -6,086,522 USD | -8,891,945 USD | -2,805,423 USD | — | -19,144,998 USD | -5,352,890 USD | -8,999,055 USD | -2,828,068 USD |
| Operating profitIncome statement | -2,925,607 USD | -5,109,786 USD | — | — | -16,703,604 USD | -1,818,715 USD | -5,297,179 USD | -2,645,319 USD |
| RevenueIncome statement | 18,986,376 USD | 36,914,268 USD | — | — | 65,271,815 USD | 17,110,425 USD | 45,568,655 USD | 14,745,702 USD |
| Total assetsBalance sheet | 61,461,954 USD | — | — | 65,477,518 USD | 65,477,518 USD | 69,492,758 USD | — | — |
| Total equityBalance sheet | 20,674,483 USD | — | 19,826,359 USD | 18,424,629 USD | 18,424,629 USD | 23,134,884 USD | — | 26,231,633 USD |
| Total liabilitiesBalance sheet | 40,787,471 USD | — | — | 47,052,889 USD | 47,052,889 USD | 46,357,874 USD | — | — |
| Capital expendituresCash flow statement | — | 75,036 USD | — | — | 55,675 USD | — | 47,780 USD | — |
| Financing cash flowCash flow statement | — | 2,136,372 USD | — | — | 14,056,091 USD | — | 9,357,403 USD | — |
| Investing cash flowCash flow statement | — | -594,358 USD | — | — | -2,014,855 USD | — | -945,282 USD | — |
| Operating cash flowCash flow statement | — | -2,785,320 USD | — | — | -8,447,614 USD | — | -3,851,273 USD | — |
| Report source | Open report ↗ Published: 08/18/2026 | Open report ↗ Published: 08/18/2026 | Open report ↗ Published: 08/18/2026 | Open report ↗ Published: 08/18/2026 | Open report ↗ Published: 04/15/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/18/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.